18 results
6-K
EX-10.1
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
or exercise price or applicable performance goals), and the criteria included in, outstanding Awards;
(v)To replace such Award with other rights
F-3/A
CNTB
Connect Biopharma Holdings Ltd
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
will require substantial additional financing to achieve our goals.
Risks Related to the Discovery, Development and Regulatory Approval of Our Product … will require substantial additional financing to achieve our goals.
Risks Related to the Discovery, Development and Regulatory Approval of Our
F-3/A
CNTB
Connect Biopharma Holdings Ltd
20 May 22
Shelf registration (foreign) (amended)
6:54pm
financing to achieve our goals.
Risks Related to the Discovery, Development and Regulatory Approval of Our Product Candidates
Clinical drug development … it.
We will require substantial additional financing to achieve our goals.
Risks Related to the Discovery, Development and Regulatory Approval
F-3
umd as4s1
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
7njydyrsz4bdbn6
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.10
qx94doikp2tctlrysu3y
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.11
c72zkwp
31 Mar 22
Annual report (foreign)
4:33pm
424B4
tlq6yfp0zot85h 2nsgs
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
l86kv4n3
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
EX-10.3
libqpfvxg 3km0r
17 Mar 21
Registration statement (foreign) (amended)
6:38am
F-1/A
EX-10.3
q73nea5
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
yjx7dcgp
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
8ys6igeg3jy9x0mp1h
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.14
ii57kyg
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
3kl1ev
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
hw9kw1
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next